ArticleAlzheimer's research & therapy2011
Investigational drugs for the treatment of AD: what can we learn from negative trials?
Sandra A Jacobson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it